SPIA
ANIK icon

Steward Partners Investment Advisory’s Anika Therapeutics ANIK Stock Holding History

Steward Partners Investment Advisory’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-300
Closed -$12.2K – 7085
2021
Q1 		$12.2K Hold
300
– – ﹤0.01% 2693
2020
Q4 		$14K Hold
300
– – ﹤0.01% 2170
2020
Q3 		$11K Hold
300
– – ﹤0.01% 2088
2020
Q2 		$11K Buy
+300
New +$9.88K ﹤0.01% 1991
2017
Q3 		– Sell
-18
Closed – – 1664
2017
Q2 		$0 Buy
+18
New +$829 ﹤0.01% 1611

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Steward Partners Investment Advisory's ANIK Position: Q2 2021 in Review

Steward Partners Investment Advisory sold out of Anika Therapeutics (ANIK) in Q2 2021, closing a stake of 300 shares — an estimated $12.2K sold.

Steward Partners Investment Advisory first reported a position in ANIK in Q2 2017 and held it in 5 quarters. The position peaked at $14K in Q4 2020. 139 funds tracked by Wall St. Rank hold ANIK as of Q2 2021.

  • Steward Partners Investment Advisory reported no remaining Anika Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 300 Anika Therapeutics shares in Q2 2021, an estimated $12.2K.
  • Steward Partners Investment Advisory first reported a position in Anika Therapeutics in Q2 2017 and held it in 5 quarters.
  • Steward Partners Investment Advisory's Anika Therapeutics position peaked at $14K in Q4 2020.
  • 139 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2021, filed 13 Aug 2021.